21.09.2017 • NewsArkemaElaine BurridgeRenewable Energy

Arkema to Hike US Fluoropolymer Capacity

(c) Arkema
(c) Arkema

Arkema is expanding capacity for its Kynar polyvinylidene fluoride (PVDF) in Calvert City, USA, by about 20%, with work set to start in mid-2018. A start-up date and capacity details were not disclosed.

The expansion, said Arkema, has been prompted by strong demand in the new energies and water management markets as well as in the more traditional applications of chemical processing and high-performance cables.

In April, the French specialty chemicals group brought on stream new Kynar PVDF capacities in Changshu, China. The plant’s capacity was increased by 25% to meet its customers’ growth in the region, especially in new energies (batteries and photovoltaics) and water management markets, as well as in construction coatings and chemical processing.  The facility, which started operating in 2011, previously underwent a capacity hike of 50% in 2012.

According to US market consultancy Grand View Research, the global PVDF market is expected to increase at a compound annual growth rate (CAGR) of 7.6% from 2017 to 2025.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.